Pharmaceutical

Ransomware attack shuts down hospital emergency rooms i...

In the latest edition of STAT's Health Tech newsletter: a ransomware attack wrea...

STAT+: More drugmakers are filing continuation patents ...

More drugmakers are filing continuation patents that allow them to sideline gene...

Half of people worldwide at risk of developing mental h...

Mental health conditions are common — but that "doesn't weaken or abrogate the f...

Senators push IRS to launch nonprofit hospital probe

A bipartisan group of senators wants federal tax regulators to probe nonprofit h...

STAT+: Pharmalittle: Novo’s Wegovy obesity drug lowers ...

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by ...

STAT+: Beleaguered drug manufacturer Emergent cuts jobs...

Emergent BioSolutions, which into hot water in 2021 due to a contamination issue...

STAT+: DNA-sequencing giant Illumina slashes 2023 reven...

After starting the year by lowering its 2023 revenue projections, San Diego-base...

CDC director overhauls leadership of center that oversa...

The new director of the CDC, Mandy Cohen, is overhauling the leadership of the C...

Study shows autistic people are more likely to engage i...

“When we are raised to believe we are broken and defective ... is it any wonder ...

Study mapping how SARS-CoV-2 disrupts mitochondria sugg...

The SARS-CoV-2 virus hijacks our cellular power plants known as mitochondria. A ...

Nonprofit naloxone maker celebrates FDA approval by don...

Naloxone is viewed as a critical way of fighting the opioid epidemic. But its hi...

Meet the scientists trying to stop the next global pand...

“Everybody in the world should be a sentinel, a sentinel not only for his own im...

STAT+: Pharmalittle: Wegovy heart study has docs seeing...

A new study of Wegovy is expected to have a big impact on how clinicians approac...

Opinion: Public pharma is the best solution to the ongo...

Most of the solutions being discussed for drug shortages are just Band-Aids on a...

Opinion: STAT+: One way to create resilient drug supply...

The key to the standardized implementation of this innovation lies in providing ...

‘Underwhelming’: NIH trials fail to test meaningful lon...

The NIH says it’s used up most of its $1.15 billion of long Covid funding and mo...